Evidence map›Paper›PMID 30531807›Full record

ArticleJournal of human genetics2019

Identification of novel LFNG mutations in spondylocostal dysostosis.

Nao Otomo, Shuji Mizumoto, Hsing-Fang Lu, Kazuki Takeda, Belinda Campos-Xavier, Lauréane Mittaz-Crettol, Long Guo, Kazuharu Takikawa, Masaya Nakamura, Shuhei Yamada and 3 more

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Journal of human genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Novel Splice Variant in theDiagnostics (Basel, Switzerland) · 2025
    Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Other Types of Glycosylation.Advances in experimental medicine and biology · 2021
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Nao OtomoLaboratory of Bone and Joint Diseases, Center for Integrative Medical Sciences RIKEN, Tokyo, Japan.
Shuji MizumotoDepartment of Pathobiochemistry, Faculty of Pharmacy, Meijo University, Nagoya, Japan.
Hsing-Fang LuLaboratory of Bone and Joint Diseases, Center for Integrative Medical Sciences RIKEN, Tokyo, Japan.
Kazuki TakedaLaboratory of Bone and Joint Diseases, Center for Integrative Medical Sciences RIKEN, Tokyo, Japan.
Belinda Campos-XavierDivision of Genetic Medicine, Center for Molecular Diseases, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Lauréane Mittaz-CrettolDivision of Genetic Medicine, Center for Molecular Diseases, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Long GuoLaboratory of Bone and Joint Diseases, Center for Integrative Medical Sciences RIKEN, Tokyo, Japan.
Kazuharu TakikawaDepartment of Orthopedics, Shizuoka Children's Hospital, Shizuoka, Japan.
Masaya NakamuraDepartment of Orthopaedic Surgery, Keio University School of Medicine, Tokyo, Japan.
Shuhei YamadaDepartment of Pathobiochemistry, Faculty of Pharmacy, Meijo University, Nagoya, Japan.
Morio MatsumotoDepartment of Orthopaedic Surgery, Keio University School of Medicine, Tokyo, Japan.
Kota WatanabeDepartment of Orthopaedic Surgery, Keio University School of Medicine, Tokyo, Japan. watakota@gmail.com.
Shiro IkegawaLaboratory of Bone and Joint Diseases, Center for Integrative Medical Sciences RIKEN, Tokyo, Japan. sikegawa@ims.u-tokyo.ac.jp.
RIKEN Center for Integrative Medical Sciences · JPKeio University · JPMeijo University · JPUniversity of Lausanne · CHShizuoka Children's Hospital · JP

Funding

Japan Agency for Medical Research and Development (AMED) 17ek0109212h0001Japan Agency for Medical Research and Development (AMED) 17ek0109280h0001Japan Society for the Promotion of Science (JSPS) 16K08251Japan Society for the Promotion of Science (JSPS) 17K16710
6 · The paper itself

Abstract

Spondylocostal dysostosis (SCDO) is a heterogeneous group of skeletal disorders characterized by multiple segmentation defects involving vertebrae and ribs. Seven disease genes have been reported as causal genes for SCDO: DLL3, MESP2, TBX6, HES7, RIPPLY2, DMRT2, and LFNG. Here we report a Japanese SCDO case with multiple severe vertebral anomalies from cervical to sacral spine. The patient was a compound heterozygote for c.372delG (p.K124Nfs*) and c.601G>A (p.D201N) variants of LFNG, which encodes a glycosyltransferase (O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase). The missense variant was in the DxD motif, an active-site motif of the glycosyltransferase, and its loss of the enzyme function was confirmed by an in vitro enzyme assay. This is the second report of LFNG mutations in SCDO.

Indexed as

MutationAbnormalities, MultipleAmino Acid SequenceGlucosyltransferasesGlycosyltransferasesHernia, DiaphragmaticHexosyltransferasesHumansInfantIntracellular Signaling Peptides and ProteinsMaleMembrane ProteinsPrognosisSequence HomologyGlucosyltransferasesGlycosyltransferasesHexosyltransferasesIntracellular Signaling Peptides and ProteinsLFNG protein, humanMembrane ProteinsMFNG protein, human

Identifiers

PMID30531807
OpenAlexW2904501677

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.